SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-019623
Filing Date
2023-05-09
Accepted
2023-05-09 16:06:02
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20230509.htm   iXBRL 8-K 61309
2 EX-99.1 lbph-ex99_1.htm EX-99 214005
3 GRAPHIC img58896055_0.jpg GRAPHIC 11946
  Complete submission text file 0000950170-23-019623.txt   435206

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20230509.xsd EX-101.SCH 2495
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20230509_lab.xml EX-101.LAB 18440
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20230509_pre.xml EX-101.PRE 12053
8 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20230509_htm.xml XML 5113
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 23901915
SIC: 2834 Pharmaceutical Preparations